Replies to post #2448 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Shionogi's drug is also teratogenic, which may give some people pause about using it.

[willyw]

Hmmmmmm.
Some potential validation?

6) The FDA is currently exploring long covid treatments as a potential label for antivirals.

Enanta Pharmaceuticals to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Poster Presentations:
Date: Monday, April 17, 2023
Time: 12:00 – 1:30 p.m. Central European Summer Time (CEST)
Session Title: 12e. Drug development and treatment modalities (including in vitro, animal, clinical trials, resistance)
Poster Number: P2633
Title: “EDP-235, a Potent, Once-Daily, Oral Antiviral, Demonstrates Potential for Treatment and Prevention of Long COVID”
Presenter: Yang Li, Ph.D.
---------------------
It's probably pointless to comment but I am assuming that being accepted to present at (ECCMID) offers some validity to the presentations.